ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,749.00
0.35%
S&P ASX All Technology
3,067.50
0.14%
Brent Oil
83.715
-0.28%
US Dollar vs AUD
1.51607
0.35%
Bitcoin
61,737.31
-2.09%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. T2 Biosystems Inc (TTOO)

  7. T2 Biosystems Inc (TTOO) News

TTOO

T2 Biosystems (TTOO)

T2 Biosystems Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TTOO
DateTimeSourceHeadlineSymbolCompany
08/05/202409:46Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TTOOT2 Biosystems Inc
08/05/202406:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTOOT2 Biosystems Inc
08/05/202406:48Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTOOT2 Biosystems Inc
07/05/202423:00GlobeNewswire Inc.T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme DiseaseNASDAQ:TTOOT2 Biosystems Inc
07/05/202407:27Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:TTOOT2 Biosystems Inc
07/05/202407:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTOOT2 Biosystems Inc
07/05/202407:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TTOOT2 Biosystems Inc
07/05/202406:34GlobeNewswire Inc.T2 Biosystems Announces First Quarter 2024 Financial ResultsNASDAQ:TTOOT2 Biosystems Inc
07/05/202406:34GlobeNewswire Inc.T2 Biosystems Announces Commercial Expansion Through Middle East DistributorNASDAQ:TTOOT2 Biosystems Inc
07/05/202406:29GlobeNewswire Inc.T2 Biosystems Announces the Conversion of an Additional $15 Million of CRG Term Loan into EquityNASDAQ:TTOOT2 Biosystems Inc
06/05/202421:48Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:TTOOT2 Biosystems Inc
24/04/202423:00GlobeNewswire Inc.T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024NASDAQ:TTOOT2 Biosystems Inc
12/04/202406:05GlobeNewswire Inc.T2 Biosystems Shareholders Vote for CRG Debt Conversion into EquityNASDAQ:TTOOT2 Biosystems Inc
29/03/202400:00GlobeNewswire Inc.T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.NASDAQ:TTOOT2 Biosystems Inc
20/03/202422:30GlobeNewswire Inc.T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business UpdatesNASDAQ:TTOOT2 Biosystems Inc
20/03/202400:00GlobeNewswire Inc.T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business UpdatesNASDAQ:TTOOT2 Biosystems Inc
19/03/202400:00GlobeNewswire Inc.T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance PanelNASDAQ:TTOOT2 Biosystems Inc
13/03/202400:00GlobeNewswire Inc.T2 Biosystems Receives Extension to Comply with Nasdaq Listing RequirementNASDAQ:TTOOT2 Biosystems Inc
05/03/202408:34Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TTOOT2 Biosystems Inc
28/02/202408:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTOOT2 Biosystems Inc
28/02/202408:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTOOT2 Biosystems Inc
28/02/202408:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTOOT2 Biosystems Inc
21/02/202408:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTOOT2 Biosystems Inc
21/02/202408:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTOOT2 Biosystems Inc
21/02/202408:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTOOT2 Biosystems Inc
21/02/202408:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTOOT2 Biosystems Inc
17/02/202409:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTOOT2 Biosystems Inc
17/02/202409:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTOOT2 Biosystems Inc
16/02/202408:49Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TTOOT2 Biosystems Inc
16/02/202408:47Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTOOT2 Biosystems Inc
 Showing the most relevant articles for your search:NASDAQ:TTOO

Your Recent History

ASX
WBC
Westpac Banking
ASX
NCM
Newcrest Mining
FX
AUDCAD
AUD vs CAD
ASX
ORG
Origin Energy
ASX
WDC
Westfield
FX
EURAUD
Euro vs AUD
NASDAQ
TSLA
Tesla
ASX
SUN
Suncorp
NYSE
XOM
Exxon Mobil
FX
AUDJPY
AUD vs Yen
ASX
TLS
Telstra
NASDAQ
AAPL
Apple
ASX
XTO
S&P ASX 100
COIN
BTCUSD
Bitcoin
ASX
RIO
Rio Tinto
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved